FDA issues complete response letter for tralokinumab in moderate to severe atopic dermatitis May 3, 2021
Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance April 23, 2021
Baricitinib improves hair regrowth in patients with alopecia areata in second BRAVE-AA trial April 21, 2021
RSS